March 2013

Applications are invited for the position of Junior Research Fellow (JRF) in Department of Biotechnology (DBT) sponsored project “Targeting the mitochondria dependent and independent apoptotic signaling by Nanoparticulate drug conjugate to induce apoptosis in cancer cells”.

Position: One Junior Research Fellow

About Auhtor:
Avula Parthasarthi Yadav*,
Krishna Theja Pharmacy College,
Jawaharlal Nehru University, Anantapur.
*parthu298@gmail.com

1. Introduction
Currently natural products are gaining popularity to combat various physiological threats including oxidative stress, cardiovascular complexities, cancer insurgence, and immune dysfunction. The use of traditional remedies may be encountered more frequently due to an array of scientific evidence in their favor¹.  It has been well established that nutrition plays an important role in the etiology of hyperlipidimia, atherosclerosis and other coronary heart disease (CHD) complications like myocardial infarction¹.
The etiology and pathogencity of coronary heart diseases lie in the casual relationship between the development of atherosclerosis, elevated plasma lipid percentage cholesterol levels in blood and plasma, genetic makeup, endicrinological aberration, immunologic and autonomic factors, blood flow and coagulation².

inVentiv Health Clinical, a leader in drug development services, has a global infrastructure, therapeutic expertise, and commitment to quality that is unmatched in the industry. For pharmaceutical, biotechnology, generic drug, and medical device companies of all sizes around the world, inVentiv Health Clinical can help you transform promising ideas into commercial reality.

The University of Hyderabad (UoH), one of the major institutions of higher education in India is largely devoted to postgraduate studies and is widely known for its excellence in research and for its distinguished faculty. Founded in 1974 with Prof. Gurbaksh Singh as its first Vice Chancellor, UoH - also known as Hyderabad Central University or HCU- has emerged as a leading centre of teaching and research.

The Wellcome Trust/DBT India Alliance is an £80 million initiative funded equally by The Wellcome Trust, UK and Department of Biotechnology, India. The broad aim of the India Alliance is to build excellence in the Indian biomedical scientific community by supporting future leaders in the field. To achieve this we provide competitive Fellowships across the full spectrum of biomedical science: from fundamental biology through to clinical and public health research.

The ICGEB is an international, nonprofit research organization. Established as a special project of UNIDO, it became fully autonomous in 1994 and now counts over 60 Member States.